日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Schizosaccharomyces pombe RNA polymerase II-associated protein rba50 (rba50) CSB-YP526122SXV
CSB-EP526122SXV
CSB-BP526122SXV
CSB-MP526122SXV
CSB-EP526122SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Centromere/microtubule-binding protein CBF5 (cbf5) CSB-YP526123EKF
CSB-EP526123EKF
CSB-BP526123EKF
CSB-MP526123EKF
CSB-EP526123EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica Calcium-transporting ATPase 1 (PMR1), partial CSB-YP526124YAP
CSB-EP526124YAP
CSB-BP526124YAP
CSB-MP526124YAP
CSB-EP526124YAP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Agaricus bisporus Hydrophobin-B (hypB) CSB-YP526125AYJ
CSB-EP526125AYJ
CSB-BP526125AYJ
CSB-MP526125AYJ
CSB-EP526125AYJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Human Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (PDE6D) CSB-YP526126HU
CSB-EP526126HU
CSB-BP526126HU
CSB-MP526126HU
CSB-EP526126HU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phosphomannomutase (PMM) CSB-YP526127BPY
CSB-EP526127BPY
CSB-BP526127BPY
CSB-MP526127BPY
CSB-EP526127BPY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila pseudoobscura pseudoobscura Glyceraldehyde-3-phosphate dehydrogenase 2 (Gapdh2) CSB-YP526128DME
CSB-EP526128DME
CSB-BP526128DME
CSB-MP526128DME
CSB-EP526128DME-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemonchus contortus 32 kDa beta-galactoside-binding lectin (GAL-1) CSB-YP526129HSW
CSB-EP526129HSW
CSB-BP526129HSW
CSB-MP526129HSW
CSB-EP526129HSW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Integrin alpha-PS3 (scb), partial CSB-YP526130DLU
CSB-EP526130DLU
CSB-BP526130DLU
CSB-MP526130DLU
CSB-EP526130DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Drosophila melanogaster Protein DGCR14 homolog (Es2), partial CSB-YP526131DLU
CSB-EP526131DLU
CSB-BP526131DLU
CSB-MP526131DLU
CSB-EP526131DLU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant EGF-like domain-containing protein C02B10.3 (C02B10.3), partial CSB-YP526132CXY
CSB-EP526132CXY
CSB-BP526132CXY
CSB-MP526132CXY
CSB-EP526132CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant M-phase inducer phosphatase cdc-25.1 (cdc-25.1), partial CSB-YP526133CXY
CSB-EP526133CXY
CSB-BP526133CXY
CSB-MP526133CXY
CSB-EP526133CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neuropeptide-like protein 29 (nlp-29) CSB-YP526134CXY
CSB-EP526134CXY
CSB-BP526134CXY
CSB-MP526134CXY
CSB-EP526134CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Macrophage migration inhibitory factor homolog (MIF) CSB-YP526135WBS
CSB-EP526135WBS
CSB-BP526135WBS
CSB-MP526135WBS
CSB-EP526135WBS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Caenorhabditis elegans Alpha-tubulin N-acetyltransferase 1 (mec-17) CSB-YP526136CXY
CSB-EP526136CXY
CSB-BP526136CXY
CSB-MP526136CXY
CSB-EP526136CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Folate-like transporter 2 (folt-2), partial CSB-YP526137CXY
CSB-EP526137CXY
CSB-BP526137CXY
CSB-MP526137CXY
CSB-EP526137CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serpentine receptor class epsilon-13 (sre-13), partial CSB-YP526138CXY1
CSB-EP526138CXY1
CSB-BP526138CXY1
CSB-MP526138CXY1
CSB-EP526138CXY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Kinetochore-binding protein 3 (kbp-3) CSB-YP526139CXY
CSB-EP526139CXY
CSB-BP526139CXY
CSB-MP526139CXY
CSB-EP526139CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nuclear hormone receptor family member nhr-108 (nhr-108) CSB-YP526140CXY
CSB-EP526140CXY
CSB-BP526140CXY
CSB-MP526140CXY
CSB-EP526140CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Nuclear hormone receptor family member nhr-111 (nhr-111) CSB-YP526141CXY
CSB-EP526141CXY
CSB-BP526141CXY
CSB-MP526141CXY
CSB-EP526141CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶(hù)提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×